CannabisNewsBreaks

WednesdayDec 04, 2019 9:38 am

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Commence Trading on the Toronto Stock Exchange on December 5

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) on Tuesday announced its receipt of final approval to list its common shares on the Toronto Stock Exchange (the "TSX"). According to the update, Willow’s common shares will commence trading on the TSX effective as of the open of the market on Thursday, December 5, 2019. The common shares will continue to trade under the symbol "WLLW" upon listing on the TSX. In conjunction with the TSX listing, the common shares will concurrently be delisted from the Canadian Securities Exchange. To view the full press release, visit http://cnw.fm/il5AE About Willow Biosciences Inc. Willow is…

Continue Reading

TuesdayDec 03, 2019 10:07 am

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Comments on DEA Descheduling Partner’s CBD

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced cannabidiol (“CBD”), this morning issued a release commenting on the recent news that the U.S. Drug Enforcement Agency (“DEA”) has removed Purisys, LLC’s CBD from Schedule I of the Controlled Substances Act (“CSA”). Purisys, the spin-out entity of Noramco, Inc.’s cannabinoids business, began operating as a stand-alone entity on October 1, 2019 and is expected to become independent from Noramco on January 1, 2020. Per the terms of a joint development agreement, Noramco is Willow's exclusive manufacturing and distribution partner. Willow holds…

Continue Reading

WednesdayNov 27, 2019 10:21 am

CannabisNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Advances Toward Equipment Installation at Hemp-Biomass Extraction Facility

HTC Extraction Systems (TSX.V: HTC), a hemp-biomass processing entity, recently completed its 19,000-square-foot facility in Port Lajord and is anticipating the arrival of its initial new extraction equipment in December 2019. An article discussing the company reads, “Installation of the extraction and formulation equipment will mark the next major stage for the company’s strategy of building on hemp biomass tolling contracts on both sides of the U.S.-Canada border to extract CBD full-spectrum oil (‘FSO’) and to keep a percentage of the distillate for future sales and offtake agreements, including sales to the cannabinoid pharmaceutical market. Bought-deal, private-placement financing that closed…

Continue Reading

TuesdayNov 26, 2019 2:15 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Set to Profit from FDA’s MRTP Pathway Announcement

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator with technology that has demonstrated its ability to enhance the oral delivery of nicotine, is positioned to benefit from the FDA’s recent announcement that it had authorized the marketing of eight smokeless tobacco products through the modified-risk, tobacco-product (“MRTP”) pathway (http://cnw.fm/PaC87). An article discussing the company reads, “The FDA approval of the ‘modified risk’ claims was made after reviewing scientific evidence submitted by the manufacturer of the products. The approvals, which are product specific and expire after five years, do not mean the products come with no health risks. Nicotine-based products are…

Continue Reading

TuesdayNov 26, 2019 12:34 pm

CannabisNewsBreaks – Dama Financial to Offer Free Banking Access to Eligible Cannabis-Related Businesses

Dama Financial, a leading provider of access to electronic banking and payment solutions, this morning announced its plan to offer cannabis-related businesses (“CRBs”) that qualify under its Social Equity Program (“SEP”) free access to banking. The company has designed the financial infrastructure specifically for CRBs that are impeded by the shortcomings related to cash-based operations. Businesses that qualify for application to their respective state or county’s SEP are now authorized to apply to Dama’s SEP and obtain free access to banking. To view the full press release, visit http://cnw.fm/XvK1L About Dama Financial Dama Financial provides transparent, sustainable banking and payment…

Continue Reading

TuesdayNov 26, 2019 10:04 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Bolsters its Strategic Advisory Board with Kevin Durant’s Thirty Five Ventures

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the expansion of its strategic advisory board to add Thirty Five Ventures, the business owned by NBA star Kevin Durant and sports business executive Rich Kleiman. According to the update, Thirty Five Ventures will collaborate with Canopy Rivers as it continues to pursue its global growth strategy and strengthen its global portfolio of leading cannabis companies. Canopy Rivers will also look to co-invest with Thirty Five Ventures on cannabis-related deals, leveraging the group's expertise in brand development and marketing. "We're thrilled to have Thirty Five…

Continue Reading

MondayNov 25, 2019 2:11 pm

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Receipt of Conditional Approval to List on the Toronto Stock Exchange

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced its receipt of conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares on the TSX. According to the update, final approval of the listing is subject to Willow Biosciences meeting certain TSX customary conditions, and Willow will issue a statement upon TSX’s confirmation of the commencement date. "Listing on the TSX is a significant milestone for Willow. The TSX will broaden our investment appeal and leave us well positioned to execute on our strategic initiatives for 2020 and beyond,” Willow President and Chief Executive Officer Trevor…

Continue Reading

MondayNov 25, 2019 12:44 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces Date for Scheduled Release of Q3 2019 Results, Conference Call and Webcast

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) today announced plans to release its financial results for the third quarter ended September 30, 2019 after market close on Friday, November 29, 2019. In addition, the company will host a conference call and webcast at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time on Monday, December 2, 2019, to discuss its results and recent corporate highlights. Interested parties may access the call by dialing 1-877-407-0784 (toll-free) or 201-689-8560 (toll/international) and requesting the Plus Products Earnings Call or providing confirmation code 13696648. The call will be webcast on the Plus Products Investor…

Continue Reading

MondayNov 25, 2019 11:26 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Expands Canadian Distribution, Initiates Cultivation at Valleyfield Hybrid Greenhouse

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced receipt of its inaugural purchase order from the BC Liquor Distribution Branch ("BCLDB"), further expanding its Canadian distribution footprint. The company also obtained a Health Canada license amendment, allowing it to launch cultivation operations at its flagship Valleyfield hybrid greenhouse. With the addition of British Columbia, TGOD now has the ability to distribute its products to a total of 527 retail locations across five provinces, or 82% of Canada's current store count. In 2020, the number of cannabis stores is poised…

Continue Reading

MondayNov 25, 2019 10:10 am

CannabisNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Announces Q4 and 2019 Fiscal Year Results

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its results for the fourth quarter and fiscal year ended August 31, 2019 (“Q4” or “Q4 2019”). Among the highlights, Organigram reported a 547% growth in 2019 net revenue to $80.4 million from $12.4 million in 2018, and a 575% increase in 2019 gross margin, before fair value changes to biological assets and inventory, to $37.9 million or 47% of net revenue from $5.6 million or 45% of net revenue in 2018. “Our 2019 results reflected a successful year…

Continue Reading